Authors: Ballo, MT Zagars, GK Pisters, PWT Feig, BW Patel, SR Von Eschenbach, AC

Citation: Mt. Ballo et al., Spermatic cord sarcoma: Outcome, patterns of failure and management, J UROL, 166(4), 2001, pp. 1306-1310

Authors: Ozen, M Hopwood, VL Balbay, MD Johnston, DA Babaian, RJ Logothetis, CJ Von Eschenbach, AC Pathak, S

Citation: M. Ozen et al., Correlation of non-random chromosomal aberrations in lymphocytes of prostate cancer patients with specific clinical parameters, INT J ONCOL, 17(1), 2000, pp. 113-117

Authors: Multani, AS Ozen, M Agrawal, A Hopwood, VL Von Eschenbach, AC Pathak, S

Citation: As. Multani et al., Amplification of the Y chromosome in three murine tumor cell lines transformed in vivo by different human prostate cancers, IN VITRO-AN, 35(4), 1999, pp. 236-239

Authors: Multani, AS Ozen, M Sen, S Mandal, AK Price, JE Fan, D Radinsky, R Ali-Osman, F Von Eschenbach, AC Fidler, IJ Pathak, S

Citation: As. Multani et al., Amplification of telomeric DNA directly correlates with metastatic potential of human and murine cancers of various histological origin, INT J ONCOL, 15(3), 1999, pp. 423-429

Authors: Czerniak, B Chaturvedi, V Li, L Hodges, S Johnston, D Ro, JY Luthra, R Logothetis, C Von Eschenbach, AC Grossman, HB Benedict, WF Batsakis, JG

Citation: B. Czerniak et al., Superimposed histologic and genetic mapping of chromosome 9 in progressionof human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer, ONCOGENE, 18(5), 1999, pp. 1185-1196

Authors: Navone, NM Labate, ME Troncoso, P Pisters, LL Conti, CJ Von Eschenbach, AC Logothetis, CJ

Citation: Nm. Navone et al., p53 mutations in prostate cancer bone metastases suggest that selected p53mutants in the primary site define foci with metastatic potential, J UROL, 161(1), 1999, pp. 304-308